Engineering researchers at the University of Arkansas have moved closer to developing an alternative method of detecting and possibly treating breast cancer.
Mar 1, 2018
0
7
A research team at the University of California, Riverside has discovered a way for chemotherapy drug paclitaxel to target migrating, or circulating, cancer cells, which are responsible for the development of tumor metastases.
Feb 23, 2018
0
294
Breast cancer is the most commonly diagnosed cancer in women—one in eight (12.4 percent) in the U.S. will be diagnosed with it. Invasive breast cancer is dangerous for two reasons: It can aggressively spread to other organs ...
Feb 21, 2018
0
6
Stanford University researchers report that injecting mice with inactivated induced pluripotent stem cells (iPSCs) launched a strong immune response against breast, lung, and skin cancers. The vaccine also prevented relapses ...
Feb 15, 2018
0
689
Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or ...
Feb 15, 2018
0
519
A study by scientists at the University of Arizona Cancer Center and Cancer Research UK has found that the loss of a specific tumor suppressor in "triple-negative" breast cancer provides clues about potential new approaches ...
Feb 5, 2018
0
375
New drugs that activate the immune system to target cancer cells have improved the lives of many patients with cancer. However, immunotherapies are not effective in all patients, and the success of these therapies depends ...
Jan 30, 2018
0
5
A new anti-cancer strategy wields light as a precision weapon. Unlike traditional light therapy—which is limited to the skin and areas accessible with an endoscope—this technique can target and attack cancer cells that ...
Jan 26, 2018
0
230
Aggressive cancers like glioblastoma and metastatic breast cancer have in common a siren call that beckons the bone marrow to send along whatever the tumors need to survive and thrive.
Jan 23, 2018
1
992
A new genetic-based model may explain how a common form of early-stage breast cancer known as ductal carcinoma in situ (DCIS) progresses to a more invasive form of cancer say researchers at The University of Texas MD Anderson ...
Jan 4, 2018
0
8
